Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tyson Foods, Inc. of Class Action Lawsuit and Upcoming Deadline – TSN

12/04/2016 | 08:01pm EDT

NEW YORK, Dec. 04, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tyson Foods, Inc. (“Tyson” or the “Company”) (NYSE:TSN) and certain of its officers.   The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-08108, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Tyson securities between November 23, 2015 and October 6, 2016 inclusive (the “Class Period”).  This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”). 

If you are a shareholder who purchased Tyson securities during the Class Period, you have until December 16, 2016 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased. 

[Click here to join this class action]

Tyson, together with its subsidiaries, operates as a food company worldwide. Through its Chicken segment, Tyson raises and processes chickens into fresh, frozen, and value-added chicken products.  The Company sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors, as well as through independent brokers and trading companies.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.  Specifically, Defendants made false and/or misleading statements and/or failed to disclose that:  (i) Tyson systematically colluded with several of its industry peers to fix prices in the broiler-chicken market; (ii) the foregoing conduct constituted a violation of federal antitrust laws; (iii) consequently, Tyson’s Chicken segment revenues during the class period were the result of illegal conduct; and (iv) as a result of the foregoing, Tyson’s public statements were materially false and misleading at all relevant times. 

On September 2, 2016, the market had its first inkling of Defendants’ fraud, when food distributor Maplevale Farms, Inc. (“Maplevale”) filed an antitrust class action complaint in U.S. District Court for the Northern District of Illinois against Tyson and several other poultry producers, including Pilgrim’s Pride Corporation, Perdue Farms, Inc., and Sanderson Farms, Inc., alleging that Tyson and the other companies named in the complaint had conspired since 2008 to manipulate the prices of broiler chickens—chickens raised specifically for meat production—by coordinating and limiting production and exchanging detailed information about prices, capacity, and sales volume, in violation of the Sherman Antitrust Act, 15 U.S.C. §§ 1-7 (the “Sherman Act”).

Between September 7, 2016 and October 7, 2016, eight more class action complaints were filed against Tyson and other poultry companies in the Northern District of Illinois, on behalf of individual consumers and indirect purchasers of broiler chickens, all alleging that Tyson had engaged in the price-manipulation scheme described in Maplevale’s complaint.

On October 7, 2016, Pivotal Research (“Pivotal”) downgraded Tyson from “Hold” to “Sell.”  Explaining the downgrade, analyst Timothy Ramey directed investors’ attention to the allegations of price manipulation by Tyson and its industry peers and described the Maplevale complaint as “powerfully convincing.”

On news of the downgrade, Tyson’s share price fell $6.63, or 8.91%, to close at $67.75 on October 7, 2016.  From the filing of the Maplevale action on September 2, 2016 to Pivotal’s downgrade on October 7, 2016, Tyson’s share price fell $8.69, or 11.37%.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

© GlobeNewswire 2016
Latest news "Companies"
05:14pLIVESTOCK HIGHLIGHTS  : Top Stories of the Day
DJ
05:13pCorn, soy rebound after sell-off as weather risks weighed
RE
05:13pWILSON SONS  : 2021 Reference Form - Fiscal Year 2020 (7th resubmission)
PU
05:11pMANITOU  : Combined General Meeting, June 17, 2021
PU
05:11pGRAIN HIGHLIGHTS  : Top Stories of the Day
DJ
05:09pAKIN GUMP STRAUSS HAUER & FELD LLP  : Advises Zimmer Energy Transition Acquisition Corp. in its $345 million IPO
PU
05:09pMelaleuca, Inc. Selects Verdant as PLM Implementation and Software Provider
BU
05:07pOntarians cancelling AZ doses after new guidance, province still offering dose choice
AQ
05:07pOCUGEN  : Notice of Lead Plaintiff Deadline for Shareholders in the Ocugen, Inc. Class Action Lawsuit
BU
05:04pTSX falls 0.72% to 19,999.59
RE
Latest news "Companies"